Capital Rx, Inc. — Form D/A
Capital Rx, Inc. of NEW YORK, NY, a company, filed a Form D amendment with the SEC on 2024-03-22. The offering totals $312.5M, of which $115.0M was reported sold. Industry: Other.
Offering
- Filed: 2024-03-22
- Form: D/A
- Accession: 0000950157-24-000490
- Industry: Other
- Exemptions: 06b
- Total offering: $312.5M
- Amount sold: $115.0M
- Remaining: $197.5M
- Investors: 1
- Date of first sale: 2024-03-06
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-508325
Issuer
- Name: Capital Rx, Inc.
- CIK: 0001782959
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 228 PARK AVENUE S., NEW YORK, NY, 10003
- Phone: 855-538-8897
Officers, directors & promoters (21)
| Name | Role | Location |
|---|
| Feby J Abraham | Director | Houston, TX |
| Lenard Marcus | Director | Hoboken, NJ |
| Jared J Kesselheim | Director | New York, NY |
| Mark J Kandrysawtz | Director | New York, NY |
| Lenard J Marcus | Director | New York, NY |
| Ryan J Kelly | Director | New York, NY |
| Robert J Mittendorff | Director | New York, NY |
| Kevin J Hill | Director | New York, NY |
| Holly J Maloney | Director | New York, NY |
| Mostafa J Kamal | Director | New York, NY |
| A. J Loiacono | Director | New York, NY |
| A. J Loiacono | Executive Officer | New York, NY |
| Daniel J Delmastro | Director | New York, NY |
| Laleh J Alemzadeh | Executive Officer | New York, NY |
| Joseph J Alexander | Director | New York, NY |
| Joseph J Alexander | Executive Officer | New York, NY |
| Laura J Alemzadeh | Executive Officer | New York, NY |
| A.J. Loiacono | Director | New York, NY |
| A.J. Loiacono | Executive Officer | New York, NY |
| Ryan Kelly | Director | New York, NY |
| Joseph Alexander | Director | New York, NY |
Other filings by this issuer (6)
More